Lung cancer cells. © Evotec SE

Evotec SE and Janssen Biotech Inc have agreed to co-develop targeted immuno-oncological therapies.

A new study adds weight to ongoing legal and political investigations against ExxonMobil for deliberate climate malfeasance.

© Rewind Therapeutics

With Sunstone Life Siences A/S as a new investor, Belgian remyelination specialist Rewind Therapeutics has increased its 2018 Series A funding.

Proteus mirabelis often causes UTIs. © CDC/ Dr. John J. Farmer

British researchers have created a new polymer material that may help to prevent urinary tract infections caused by catheters

Model of Avantium's FDCA plant that will start production next year. © Avantium NV

Bioplastics specialist Avantium N.V. has inked a 5-year agreement to supply Henkel with plant sugar based furandicarboxylic acid , a building block of PEF bioplastics.

Ultra-Low Freezers can be used effectively to reliably store certain types of biomarkers; 
Picture: © B Medical Systems

Maintaining the integrity of tumour biomarkers during processing and storage is of great importance for the accurate diagnosis and prognosis of many diseases, including cancers. To safely store samples for research or clinical uses, freezing procedures are used to arrest the ­degradation of biomarkers. However, the stability of these molecules depends upon long-term ­storage conditions.

© InDevR

InDevR Inc., a provider of analytical technologies for vaccines and biotherapeutics, has raised $9m in Series B financing.

© Vésale/BioFit

Phage therapy specialist Vésale Bioscience gas bageds €1.8m  from European Innovation Council (EIC) to fight antibiotic resistance (AMR).

The Great Pacific Garbage Patch, Picture: © bennymarty - stock.adobe.com

A decade ago, the news about the Great Pacific Garbage Patch went viral. Since then, a multitude of startups proliferated on a mission to create ecological alternatives to the ubiquitous fossil-based plastics. At ECBF, we are closely monitoring the emerging materials for packaging applications, by far the main use case of plastics.

© Abionyx Pharma

Abionyx Pharma SA has announced positive data from Phase IIa testing of iCER-001,  a recombinant apoA-I, as a treatment for septic patients at high risk of developing Acute Kidney Injury (AKI)